NCT02856087View on ClinicalTrials.gov

The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Pain
Interventions
DRUG

High dose Remifentanil

remifentanil infusion at 4ng/ml of Ce

DRUG

Naloxone

naloxone infusion

DRUG

Low dose remifentanil

remifentanil infusion at 1ng/ml of Ce

DRUG

Normal Saline

normal saline infusion

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02856087 - The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study | Biotech Hunter | Biotech Hunter